Development · 28 Oct 2026
TORNTPHARM, full dossier1 publisher has reported this development. Each act of reporting is below, cited.
PM IST Mumbai: Torrent Pharma reported a 9.6 per cent year-on-year (YoY) decline in net profit at Rs 534 crore for the second quarter ended this year. However, operating revenue jumped 50.8 per cent to Rs 4,979 crore, compared to Rs 3,302 crore last year, driven by incremental gains from JB Pharma.
A single act of reporting so far, corroborating sources join this record as they publish.
13 Nov 2026 · 1 publisher
Torrent Pharmaceuticals plans to launch semaglutide in Brazil over the next six to nine months.
26 Oct 2026 · 1 publisher
24 Oct 2026 · 1 publisher
This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.
New here? The reader's guide explains every page, plate by plate.
fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.